BrainStorm Cell TherapeuticsBCLI 
$0.27-0.44%24h
-0.44%24h
Global rank31840
Market cap$13.17M
Change 7d-4.00%
YTD Performance-0.44%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Market capitalization of BrainStorm Cell Therapeutics (BCLI)
As of September 2024, BrainStorm Cell Therapeutics has a market cap of $13.17M. This makes BrainStorm Cell Therapeutics the world's 31840th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of BrainStorm Cell Therapeutics from 2003 to 2024
-
Value:-
Market cap history of BrainStorm Cell Therapeutics from 2003 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $16.80M | 27.04% |
| 2023 | $13.23M | -83.54% |
| 2022 | $80.33M | -59.00% |
| 2021 | $195.93M | -11.70% |
| 2020 | $221.89M | 5.84% |
| 2019 | $209.64M | 20.56% |
| 2018 | $173.88M | -9.44% |
| 2017 | $192.01M | 54.33% |
| 2016 | $124.41M | -11.19% |
| 2015 | $140.09M | -39.92% |
| 2014 | $233.15M | 76.30% |
| 2013 | $132.25M | -18.18% |
| 2012 | $161.64M | 4.76% |
| 2011 | $154.29M | 10.53% |
| 2010 | $139.60M | -26.92% |
| 2009 | $191.03M | 333.33% |
| 2008 | $44.08M | -90.77% |
| 2007 | $477.57M | 132.14% |
| 2006 | $205.72M | -37.78% |
| 2005 | $330.63M | -77.39% |
| 2004 | $1.46B | 99.00% |
| 2003 | $734.72M | - |
BCLI Market Cap Today is $13.17M -0.44% - 17 Sept 2024
View largest stocks by market cap 
